Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
RG-6436 by Genentech USA for Urinary Tract Infections: Likelihood of Approval
RG-6436 is under clinical development by Genentech USA and currently in Phase I for Urinary Tract Infections. According to GlobalData,...
RG-6436 by Genentech USA for Acinetobacter Infections: Likelihood of Approval
RG-6436 is under clinical development by Genentech USA and currently in Phase I for Acinetobacter Infections. According to GlobalData, Phase...
RG-6436 by Genentech USA for Enterobacteriaceae Infections: Likelihood of Approval
RG-6436 is under clinical development by Genentech USA and currently in Phase I for Enterobacteriaceae Infections. According to GlobalData, Phase...
RG-6436 by Genentech USA for Pseudomonas aeruginosa Infections: Likelihood of Approval
RG-6436 is under clinical development by Genentech USA and currently in Phase I for Pseudomonas aeruginosa Infections. According to GlobalData,...